Thursday, November 29, 2012

Dr. Darius Bägli’s mentoring earns him recognition from his peers and an award from the AUA Foundation

By Alena Boczek

The American Urology Association (AUA) Foundation and the urology community have recognized Dr. Darius Bägli as the 2012 Distinguished Mentor. This honour has been bestowed upon Dr. Bägli for his track record of mentoring numerous research scholars to impeccable standards. He was selected by a panel of his peers who wanted to acknowledge the respect and admiration he has earned from the entire urologic research community.

“Dr. Bägli is an incredibly deserving recipient of the Distinguished Mentor Award,” says Dr. Janet Rossant, Chief of Research. “He consistently displays an authentic generosity and creates a supportive environment for every individual in which he interacts. The AUA Foundation  has selected a recipient who truly exemplifies the values this award represents.”

Dr. Bägli is a Senior Attending Paediatric Urologist and Associate Surgeon-In-Chief at The Hospital for Sick Children, and Senior Associate Scientist in the SickKid's Research Institute. He is also a Professor of Surgery at the University of Toronto. Dr. Bägli is currently investigating extracellular matrix biology as it pertains to wound healing and biomechanically-mediated injury in the lower urinary tract.

The Distinguished Mentor Award will be presented at the annual AUA Foundation Scholar Awards Breakfast on Monday May 21.

For more information on Dr. Bägli and his work, please see his Researchers in Profile interview.



Original content via SickKids.ca

Dr. John Brumell: A rising star in the field of Cell Biology

By Alena Boczek

SickKids researcher, Dr. John Brumell will receive the GE Healthcare New Investigator Award of the Canadian Society for Molecular BioSciences (CSMB) for his meritorious research in cellular biology. As part of this honour, Brumell will give a lecture at this year’s 55th Annual CSMB Conference, and have a manuscript published in the CSMB Bulletin. The GE Healthcare New investigator Award is given to scientists who have no more than ten years of independent research experience and have accomplished outstanding research.  

Noting his future promise and prolific authorship of high-quality publications, Dr. William Trimble, the Program Head of Cell Biology at SickKids, did not hesitate to nominate Brumell, “I think that it is without question that John Brumell is one of Canada’s rising young stars in the broader field of Cell Biology. His thirst for knowledge and creative approach to his research are what helps to drive his success.”

Brumell is a Senior Scientist in the Cell Biology Program at SickKids. His area of focus is bacteria in which examines how bacteria interact with cells to cause disease. Currently, Brumell’s research is focused on Salmonella typhimurium, a common cause of food poisoning in North America, and how autophagy, a cellular system, can target bacterial pathogens.

To learn more about Dr. John Brumell and his research read this profile story!



Original content via SickKids.ca

An investment in the future of paediatric research at SickKids


By Alena Boczek

The Honourable Leona Aglukkaq, Canada’s Minister of Health, visited The Hospital for Sick Children (SickKids) to announce a $12 million investment in childhood cancer research. Over five years, the investment from The Government of Canada, through the Canadian Institutes of Health Research (CIHR), will support four new research teams in partnership with the Garron Family Cancer Centreat SickKids, C17 council, the Canadian Cancer Society, theCancer Research Society, the Ontario Institute for Cancer Research and the Pediatric Oncology Group of Ontario.

Two of the research teams to receive this funding are led by SickKids principal investigators, Drs. Shinya Ito andPaul Nathan. Dr. Ito’s team will study how childhood leukemia treatment affects brain function, while Dr. Nathan’s team will research cardiotoxicity and evaluate the importance of genetic differences between individuals in determining who is at greatest risk of developing heart disease as a result of exposure to chemotherapeutic agents.

“As Canada’s leading paediatric academic health-care centre, SickKids sees firsthand the devastating impact cancer can have on children and their families,” says Mary Jo Haddad, SickKids President and CEO. “Through the funding from this important initiative, SickKids researchers can continue improving cancer treatments for Canada’s children and youth that will enhance the quality of life for paediatric cancer patients.”

For more information on this investment visit the CIHR website for the official news release and a detailed fact sheet.


Original content via SickKids.ca